Bristol-Myers Squibb’s KarXT Faces FDA Approval Hurdles: Analyst Issues Sell Rating Amid Labeling Concerns
Morgan Stanley analyst Terence Flynn has maintained their bearish stance on BMY stock, giving a Sell rating on September 3. Terence Flynn has ...
NBC261d
FDA approves new Alzheimer's drug to slow disease progression
The FDA has approved a groundbreaking new drug to slow the progression of Alzheimer's disease in its early stages, offering ...
Kearney Hub2d
'This is why we walk': New drug that may slow Alzheimers now offered in Kearney area
Kearney physician Dr. Bradley Rodgers will soon offer Kisunla, the first drug proven to slow the early onset of Alzheimer’s.
Stories on US FDA approving injectable Roche multiple sclerosis therapy are withdrawn
The U.S. Food and Drug Administration on Thursday approved Roche's under-the-skin injection to treat patients with multiple ...
South Florida's medical research makes strides in discovery and treatment
South Florida has been a hotbed of innovation as of late, with local companies working on cutting-edge drugs and devices, and ...
Study finds Alzheimer's drugs might boost healthy protein in brain
Researchers have discovered that Alzheimer's drugs Leqembi and Kisunla boost levels of a healthy form of protein in the brain, even as they reduce its more toxic form.
Boost Your Portfolio's Health With These 4 Large-Cap Drug Stocks
Large drug-maker stocks have witnessed a strong run this year, driven by positive pipeline news and regulatory approvals. The FDA has granted approval to 29 novel drugs this year. Innovation in the ...
San Francisco Examiner3d
Alzheimer's Drugs May Work in Whole New Way, Study Finds
THURSDAY, Sept. 11, 2024 (HealthDay News) -- Two monoclonal antibody treatments to slow Alzheimer's disease, lecanemab ...
Hosted on MSN3d
FDA-approved drug could revolutionize organ transplantation
The team had previously used another drug, SNC80, to achieve similar results in ... Their top candidate was DNP, which has ...
ALS News Today3d
FDA clears Phase 1 testing of NDC-011 dual combination ALS therapy
Donepezil is used to manage symptoms of Alzheimer’s disease by improving ... orphan drug status from the FDA, which is expected to provide a range of incentives, including seven years of market ...
BioSpace4d
What Expanded CVD Medicare Coverage May Mean for Novo Nordisk’s Wegovy
A recent study estimated that Wegovy’s label expansion beyond obesity could push Medicare spending to $145 billion annually, ...
Medscape4d
AI's Drug Revolution, Part 2: New Uses for Old Drugs
Hoping to skirt the slow pace of new drug development, researchers are leaning on AI to uncover fresh uses for known ...